CRCI is relatively common, affecting an estimated 20-70% of cancer patients. The prevalence varies depending on factors such as the type of cancer, the specific chemotherapy agents used, and individual patient characteristics. Research is ongoing to better understand the incidence and risk factors associated with this condition.
